The University of Chicago Header Logo

Connection

Ted Skolarus to 5-alpha Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications Ted Skolarus has written about 5-alpha Reductase Inhibitors.
Ted Skolarus
Connection Strength
0.236
5-alpha Reductase Inhibitors
  1. Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists. Clin Genitourin Cancer. 2024 Aug; 22(4):102103.
    View in: PubMed
    Score: 0.236
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.